Malin Corporation | MLC - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 7M 2M 2026-03
ALKERMES USD 7.93B 806M 2026-08
Avita Medical AUD 105.47M 35.32M 2025-12
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Eurofins Scientific SE EUR 12.07B 699.59M 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
IQVIA Holdings USD 42.66B 10.41B 2026-08
Lonza CHF 39.68B 980.61M 2025-06
Malin Corporation EUR 133.52M 29.05M 2026-08
Organon & Co USD 3.51B 52.64M 2026-08
Ovoca Bio EUR 5.1M 3.93M 2026-08
Revvity USD 14.32B 1.63B 2026-08
Tectonic Therapeutic USD 580M 190M 2026-03
Viatris USD 19.35B 852.41M 2026-08
Xeris Pharmaceuticals USD 1000M 303M 2026-03